| Investor | Deep Track Capital, LP |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Deep Track Capital, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | 13G | AVTX / Avalo Therapeutics, Inc. | 0 | 3,055,027 | ||||
| 2026-05-15 | 13G/A | DFTX / Definium Therapeutics, Inc. | 5,676,540 | 3,000,000 | ||||
| 2026-05-15 | 13G/A | OCUL / Ocular Therapeutix, Inc. | 11,234,132 | 20,850,000 | ||||
| 2026-05-15 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 3,000,000 | 3,600,000 | ||||
| 2026-05-15 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 5,500,000 | 6,345,244 | ||||
| 2026-05-15 | 13G/A | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 11,668,983 | 7,800,465 | ||||
| 2026-05-15 | 13G/A | GERN / Geron Corporation | 32,511,271 | 31,720,278 | ||||
| 2026-05-15 | 13G/A | CRMD / CorMedix Inc. | 4,955,487 | 6,274,076 | ||||
| 2026-05-15 | 13G/A | BCAX / Bicara Therapeutics Inc. | 2,750,000 | 4,062,500 | ||||
| 2026-05-15 | 13G/A | APLS / Apellis Pharmaceuticals, Inc. | 7,000,000 | 4,532,374 | ||||
| 2026-05-12 | 13G | PSNL / Personalis, Inc. | 5,760,627 | |||||
| 2026-05-08 | 13G | COAG / Hemab Therapeutics Holdings, Inc. | 3,600,996 | |||||
| 2026-05-08 | 13G | VRDN / Viridian Therapeutics, Inc. | 2,524,833 | 5,417,660 | ||||
| 2026-04-30 | 13G | ALT / Altimmune, Inc. | 19,417,221 | |||||
| 2026-04-07 | 13G | ALMS / Alumis Inc. | 7,362,035 | |||||
| 2026-03-17 | 13G | ACRS / Aclaris Therapeutics, Inc. | 9,345,000 | |||||
| 2026-03-11 | 13G | VERA / Vera Therapeutics, Inc. | 3,921,362 | |||||
| 2026-03-04 | 13G | IMUX / Immunic, Inc. | 0 | 11,454,000 | ||||
| 2026-02-13 | 13G/A | VRDN / Viridian Therapeutics, Inc. | 5,378,997 | 2,524,833 | ||||
| 2026-02-13 | 13G/A | TERN / Terns Pharmaceuticals, Inc. | 7,495,000 | 3,150,000 | ||||
| 2026-02-13 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 14,116,000 | 110,448 | ||||
| 2026-02-13 | 13G/A | ORKA / Oruka Therapeutics, Inc. | 1,896,780 | 2,161,510 | ||||
| 2026-02-13 | 13G/A | PALI / Palisade Bio, Inc. | 10,012,958 | 0 | ||||
| 2026-02-13 | 13G/A | OLMA / Olema Pharmaceuticals, Inc. | 3,442,833 | 0 | ||||
| 2026-02-13 | 13G/A | JBIO / Jade Biosciences, Inc. | 2,279,892 | 0 | ||||
| 2026-02-13 | 13G/A | HELP / Cybin Inc. | 3,072,250 | 2,391,505 | ||||
| 2026-02-13 | 13G/A | IMA / ImageneBio, Inc. | 878,516 | 0 | ||||
| 2026-02-13 | 13G/A | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 12,647,433 | 12,335,346 | ||||
| 2026-02-13 | 13G/A | GERN / Geron Corporation | 43,000,000 | 32,511,271 | ||||
| 2026-02-13 | 13G/A | ETNB / 89bio, Inc. | 9,356,171 | 0 | ||||
| 2026-02-13 | 13G/A | ENTA / Enanta Pharmaceuticals, Inc. | 1,484,513 | 1,956,867 | ||||
| 2026-02-13 | 13G/A | DFTX / Definium Therapeutics, Inc. | 5,676,540 | |||||
| 2026-02-13 | 13G/A | AKRO / Akero Therapeutics, Inc. | 4,400,000 | 0 | ||||
| 2026-02-12 | 13G | BCAX / Bicara Therapeutics Inc. | 2,750,000 | |||||
| 2026-02-11 | 13G/A | DVAX / Dynavax Technologies Corporation | 15,726,349 | 0 | ||||
| 2026-02-10 | 13G | OCUL / Ocular Therapeutix, Inc. | 13,095,855 | 11,234,132 | ||||
| 2026-02-10 | 13D/A | LBRX / LB Pharmaceuticals Inc | 3,352,804 | 3,352,804 | ||||
| 2026-02-10 | 13G/A | OCUL / Ocular Therapeutix, Inc. | 13,095,855 | 9,234,132 | ||||
| 2026-02-06 | 13G | PMN / ProMIS Neurosciences, Inc. | 902,561 | |||||
| 2026-01-30 | 13G | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 11,668,983 | |||||
| 2026-01-15 | 13G | IPSC / Century Therapeutics, Inc. | 13,486,400 | |||||
| 2025-12-01 | 13G | CRMD / CorMedix Inc. | 4,955,487 | |||||
| 2025-11-21 | 13G | VSTM / Verastem, Inc. | 7,719,390 | |||||
| 2025-11-18 | 13G | ENGN / enGene Therapeutics Inc. | 2,239,353 | 4,317,332 | ||||
| 2025-11-14 | 13G/A | ZURA / Zura Bio Limited | 4,616,514 | 259,014 | ||||
| 2025-11-14 | 13G/A | TECX / Tectonic Therapeutic, Inc. | 1,401,938 | 0 | ||||
| 2025-11-14 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 2,352,960 | 3,000,000 | ||||
| 2025-11-14 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 3,250,000 | 1,715,691 | ||||
| 2025-11-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,947,807 | 0 | ||||
| 2025-11-14 | 13G/A | OCUL / Ocular Therapeutix, Inc. | 15,458,138 | 13,095,855 | ||||
| 2025-11-14 | 13G/A | MNMD / Mind Medicine (MindMed) Inc. | 6,500,000 | 5,500,000 | ||||
| 2025-11-14 | 13G/A | JBIO / Jade Biosciences, Inc. | 2,784,648 | 2,279,892 | ||||
| 2025-11-14 | 13G/A | IVVD / Invivyd, Inc. | 9,722,254 | 0 | ||||
| 2025-11-14 | 13G/A | INO / Inovio Pharmaceuticals, Inc. | 2,593,822 | 1,314,796 | ||||
| 2025-11-14 | 13G/A | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 15,401,751 | 12,647,433 | ||||
| 2025-11-14 | 13G/A | ETNB / 89bio, Inc. | 13,816,333 | 9,356,171 | ||||
| 2025-11-14 | 13G/A | ENGN / enGene Therapeutics Inc. | 4,557,575 | 2,239,353 | ||||
| 2025-11-14 | 13G/A | AVTX / Avalo Therapeutics, Inc. | 114,775 | 0 | ||||
| 2025-11-14 | 13G/A | DNTH / Dianthus Therapeutics, Inc. | 2,357,702 | 0 | ||||
| 2025-11-14 | 13G/A | AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) | 15,272,172 | 2,568,613 | ||||
| 2025-11-12 | 13G | MLTX / MoonLake Immunotherapeutics | 4,610,071 | |||||
| 2025-11-04 | 13G | HELP / Cybin Inc. | 1,000,000 | 3,072,250 | ||||
| 2025-10-29 | 13G/A | HELP / Cybin Inc. | 58,139,535 | 1,000,000 | ||||
| 2025-10-09 | 13G | ENTA / Enanta Pharmaceuticals, Inc. | 1,484,513 | |||||
| 2025-10-08 | 13G | PALI / Palisade Bio, Inc. | 10,012,958 | |||||
| 2025-10-07 | 13G | AKRO / Akero Therapeutics, Inc. | 4,400,000 | |||||
| 2025-09-19 | 13D | LBRX / LB Pharmaceuticals Inc | 3,352,804 | |||||
| 2025-08-25 | 13G/A | DVAX / Dynavax Technologies Corporation | 17,791,486 | 15,726,349 | ||||
| 2025-08-19 | 13G | XFOR / X4 Pharmaceuticals, Inc. | 2,366,995 | |||||
| 2025-08-14 | 13G/A | ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) | 3,579,209 | 3,480,144 | ||||
| 2025-08-14 | 13G/A | ZURA / Zura Bio Limited | 6,216,327 | 4,616,514 | ||||
| 2025-08-14 | 13G/A | TERN / Terns Pharmaceuticals, Inc. | 5,576,558 | 7,495,000 | ||||
| 2025-08-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 5,750,000 | 3,947,807 | ||||
| 2025-08-14 | 13G/A | RGLS / Regulus Therapeutics Inc. | 6,888,424 | 0 | ||||
| 2025-08-14 | 13G/A | MBX / MBX Biosciences, Inc. | 3,018,935 | 2,188,592 | ||||
| 2025-08-14 | 13G/A | MAZE / Maze Therapeutics, Inc. | 3,023,484 | 3,948,910 | ||||
| 2025-08-14 | 13G/A | KRRO / Korro Bio, Inc. | 850,000 | 277,966 | ||||
| 2025-08-14 | 13G/A | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 12,300,000 | 15,401,751 | ||||
| 2025-08-14 | 13G/A | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 2,821,171 | 1,203,244 | ||||
| 2025-08-14 | 13G/A | GERN / Geron Corporation | 35,000,000 | 43,000,000 | ||||
| 2025-08-14 | 13G/A | ALLK / Allakos Inc. | 7,232,701 | 0 | ||||
| 2025-08-04 | 13G | IMA / ImageneBio, Inc. | 878,516 | |||||
| 2025-08-04 | 13G/A | IKNA / Ikena Oncology, Inc. | 2,515,513 | 0 | ||||
| 2025-07-28 | 13G | TARS / Tarsus Pharmaceuticals, Inc. | 2,352,960 | |||||
| 2025-06-20 | 13G | JBIO / Jade Biosciences, Inc. | 2,784,648 | |||||
| 2025-05-16 | 13G | APLS / Apellis Pharmaceuticals, Inc. | 6,000,000 | 7,000,000 | ||||
| 2025-05-15 | 13G/A | TERN / Terns Pharmaceuticals, Inc. | 6,100,000 | 5,576,558 | ||||
| 2025-05-15 | 13G/A | OLMA / Olema Pharmaceuticals, Inc. | 4,000,000 | 3,442,833 | ||||
| 2025-05-15 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 4,125,000 | 5,500,000 | ||||
| 2025-05-15 | 13G/A | OCUL / Ocular Therapeutix, Inc. | 9,230,769 | 15,458,138 | ||||
| 2025-05-15 | 13G/A | MNMD / Mind Medicine (MindMed) Inc. | 6,666,667 | 6,500,000 | ||||
| 2025-05-15 | 13G/A | IVVD / Invivyd, Inc. | 10,953,937 | 9,722,254 | ||||
| 2025-05-15 | 13G/A | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 9,000,000 | 12,300,000 | ||||
| 2025-05-15 | 13G/A | GH / Guardant Health, Inc. | 6,000,560 | 5,443,721 | ||||
| 2025-05-15 | 13G/A | ETNB / 89bio, Inc. | 6,477,949 | 13,816,333 | ||||
| 2025-05-15 | 13G/A | CNTX / Context Therapeutics Inc. | 7,419,355 | 7,419,355 | ||||
| 2025-05-15 | 13G/A | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 3,330,236 | 2,821,171 | ||||
| 2025-05-15 | 13G/A | ALLK / Allakos Inc. | 2,510,736 | 7,232,701 | ||||
| 2025-05-13 | 13G | ORKA / Oruka Therapeutics, Inc. | 1,896,780 | |||||
| 2025-04-10 | 13G | PTGX / Protagonist Therapeutics, Inc. | 3,250,000 | |||||
| 2025-03-26 | 13G | IMVT / Immunovant, Inc. | 1,000,000 | 9,500,000 | ||||
| 2025-03-25 | 13G | GERN / Geron Corporation | 7,575,049 | 35,000,000 | ||||
| 2025-03-24 | 13G | DNTH / Dianthus Therapeutics, Inc. | 2,357,702 | |||||
| 2025-02-14 | 13G | NRIX / Nurix Therapeutics, Inc. | 2,997,830 | 4,125,000 | ||||
| 2025-02-14 | 13G | IKNA / Ikena Oncology, Inc. | 2,515,513 | |||||
| 2025-02-14 | 13G/A | OKUR / OnKure Therapeutics, Inc. | 660,136 | 523,989 | ||||
| 2025-02-14 | 13G/A | PYXS / Pyxis Oncology, Inc. | 4,184,100 | 0 | ||||
| 2025-02-14 | 13G/A | ENGN / enGene Therapeutics Inc. | 2,250,000 | 4,557,575 | ||||
| 2025-02-14 | 13G/A | EDIT / Editas Medicine, Inc. | 5,473,086 | 0 | ||||
| 2025-02-14 | 13G/A | SWTX / SpringWorks Therapeutics, Inc. | 4,063,676 | 3,460,756 | ||||
| 2025-02-14 | 13G/A | NKTR / Nektar Therapeutics | 15,922,655 | 1,975,998 | ||||
| 2025-02-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 2,997,830 | 3,000,000 | ||||
| 2025-02-14 | 13G/A | FDMT / 4D Molecular Therapeutics, Inc. | 4,096,452 | 609,900 | ||||
| 2025-02-14 | 13G/A | SYRS / Syros Pharmaceuticals, Inc. | 699,281 | |||||
| 2025-02-14 | 13G/A | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 3,490,506 | 3,330,236 | ||||
| 2025-02-10 | 13G | TECX / Tectonic Therapeutic, Inc. | 1,401,938 | |||||
| 2025-02-07 | 13G | MAZE / Maze Therapeutics, Inc. | 3,023,484 | |||||
| 2025-01-17 | 13G | CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) | 9,274,589 | |||||
| 2025-01-13 | 13G | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 900,000 | 9,000,000 | ||||
| 2024-12-23 | 13G | ETNB / 89bio, Inc. | 2,000,000 | 6,477,949 | ||||
| 2024-12-23 | 13G | RAPT / RAPT Therapeutics, Inc. | 0 | 14,116,000 | ||||
| 2024-11-22 | 13G/A | APLS / Apellis Pharmaceuticals, Inc. | 6,000,000 | |||||
| 2024-11-22 | 13G | APLS / Apellis Pharmaceuticals, Inc. | 6,220,265 | |||||
| 2024-11-14 | 13G/A | AMAM / Ambrx Biopharma Inc. | 3,710,412 | 0 | ||||
| 2024-11-14 | 13G/A | APGE / Apogee Therapeutics, Inc. | 2,323,456 | 1,000,000 | ||||
| 2024-11-14 | 13G/A | VIGL / Vigil Neuroscience, Inc. | 3,649,726 | 1,553,996 | ||||
| 2024-11-14 | 13G/A | VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) | 32,932,392 | 25,440,200 | ||||
| 2024-11-14 | 13G/A | TVTX / Travere Therapeutics, Inc. | 7,522,281 | 531,857 | ||||
| 2024-11-14 | 13G/A | TRML / Tourmaline Bio, Inc. | 1,815,854 | 0 | ||||
| 2024-11-14 | 13G/A | AGLE / Aeglea BioTherapeutics Inc | 2,184,440 | 1,000,000 | ||||
| 2024-11-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,992,731 | 0 | ||||
| 2024-11-14 | 13G/A | SLNCF / Silence Therapeutics plc | 5,854,740 | 3,000,000 | ||||
| 2024-11-14 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 2,044,507 | 674,833 | ||||
| 2024-11-14 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 1,793,966 | 0 | ||||
| 2024-11-14 | 13G/A | ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock) | 19,125,150 | 0 | ||||
| 2024-11-14 | 13G/A | HLVX / HilleVax, Inc. | 2,900,000 | 0 | ||||
| 2024-11-14 | 13G/A | GERN / Geron Corporation | 29,583,449 | 7,575,049 | ||||
| 2024-11-14 | 13G/A | CLYM / Climb Bio, Inc. | 3,904,785 | 2,169,143 | ||||
| 2024-11-14 | 13G/A | DYN / Dyne Therapeutics, Inc. | 2,000,000 | 3,282,000 | ||||
| 2024-11-14 | 13G/A | ANAB / AnaptysBio, Inc. | 2,036,990 | 0 | ||||
| 2024-11-14 | 13G/A | AGEN / Agenus Inc. | 31,697,539 | 0 | ||||
| 2024-11-14 | 13G/A | OLMA / Olema Pharmaceuticals, Inc. | 3,040,248 | 4,000,000 | ||||
| 2024-11-14 | 13G/A | NKTR / Nektar Therapeutics | 18,400,000 | 15,922,655 | ||||
| 2024-11-14 | 13G/A | IVVD / Invivyd, Inc. | 9,000,000 | 10,953,937 | ||||
| 2024-11-14 | 13G/A | KRRO / Korro Bio, Inc. | 714,285 | 850,000 | ||||
| 2024-11-14 | 13G/A | FDMT / 4D Molecular Therapeutics, Inc. | 2,284,372 | 4,096,452 | ||||
| 2024-11-14 | 13G/A | AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) | 11,869,297 | 15,272,172 | ||||
| 2024-11-14 | 13G/A | ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) | 4,297,438 | 3,579,209 | ||||
| 2024-10-24 | 13D/A | DVAX / Dynavax Technologies Corporation | 12,526,486 | 17,791,486 | ||||
| 2024-10-23 | 13G/A | OKUR / OnKure Therapeutics, Inc. | 660,136 | |||||
| 2024-10-11 | 13G | OKUR / OnKure Therapeutics, Inc. | 684,156 | |||||
| 2024-10-07 | 13G/A | GH / Guardant Health, Inc. | 7,000,000 | 6,000,560 | ||||
| 2024-10-07 | 13G | GH / Guardant Health, Inc. | 7,000,000 | 6,580,257 | ||||
| 2024-09-23 | 13G | MBX / MBX Biosciences, Inc. | 3,018,935 | |||||
| 2024-09-16 | 13D | DVAX / Dynavax Technologies Corporation | 7,093,214 | 12,526,486 | ||||
| 2024-07-12 | 13G | VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) | 32,932,392 | |||||
| 2024-07-02 | 13G | CLYM / Climb Bio, Inc. | 3,904,785 | |||||
| 2024-05-10 | 13G | CNTX / Context Therapeutics Inc. | 7,419,355 | |||||
| 2024-04-26 | 13G | KRRO / Korro Bio, Inc. | 714,285 | |||||
| 2024-04-26 | 13G | INO / Inovio Pharmaceuticals, Inc. | 2,593,822 | |||||
| 2024-04-22 | 13G/A | ZURA / Zura Bio Limited | 4,205,000 | 6,216,327 | ||||
| 2024-04-12 | 13G | GH / Guardant Health, Inc. | 7,000,000 | |||||
| 2024-04-05 | 13G | AVTX / Avalo Therapeutics, Inc. | 114,775 | |||||
| 2024-03-22 | 13G | OLMA / Olema Pharmaceuticals, Inc. | 3,040,248 | |||||
| 2024-03-22 | 13G | CYBN / Cybin Inc. | 58,139,535 | |||||
| 2024-03-22 | 13G | RGLS / Regulus Therapeutics Inc. | 6,888,424 | |||||
| 2024-03-15 | 13G | MNMD / Mind Medicine (MindMed) Inc. | 6,666,667 | |||||
| 2024-03-08 | 13G | PYXS / Pyxis Oncology, Inc. | 4,184,100 | |||||
| 2024-02-23 | 13G | ENGN / enGene Therapeutics Inc. | 2,250,000 | |||||
| 2024-02-14 | 13G/A | VIGL / Vigil Neuroscience, Inc. | 3,684,619 | 3,649,726 | ||||
| 2024-02-14 | 13G/A | ETNB / 89bio, Inc. | 4,331,499 | 2,000,000 | ||||
| 2024-02-14 | 13G/A | AMAM / Ambrx Biopharma Inc. | 3,710,412 | 3,710,412 | ||||
| 2024-02-14 | 13G/A | ZURA / Zura Bio Limited | 4,205,000 | 4,205,000 | ||||
| 2024-02-14 | 13G/A | VRDN / Viridian Therapeutics, Inc. | 3,312,974 | 5,378,997 | ||||
| 2024-02-14 | 13G/A | VALN / Valneva SE - Depositary Receipt (Common Stock) | 10,513,265 | 7,526,807 | ||||
| 2024-02-14 | 13G/A | TVTX / Travere Therapeutics, Inc. | 4,582,000 | 7,522,281 | ||||
| 2024-02-14 | 13G/A | TERN / Terns Pharmaceuticals, Inc. | 3,560,000 | 6,100,000 | ||||
| 2024-02-14 | 13G/A | AGLE / Aeglea BioTherapeutics Inc | 7,258,056 | 2,184,440 | ||||
| 2024-02-14 | 13G/A | SWTX / SpringWorks Therapeutics, Inc. | 3,254,132 | 4,063,676 | ||||
| 2024-02-14 | 13G/A | SLNCF / Silence Therapeutics plc | 5,854,740 | 5,854,740 | ||||
| 2024-02-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,727,606 | 2,992,731 | ||||
| 2024-02-14 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 2,837,818 | 2,044,507 | ||||
| 2024-02-14 | 13G/A | NKTR / Nektar Therapeutics | 12,302,237 | 18,400,000 | ||||
| 2024-02-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,104,507 | 5,750,000 | ||||
| 2024-02-14 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 1,991,403 | 1,793,966 | ||||
| 2024-02-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 2,717,171 | 2,997,830 | ||||
| 2024-02-14 | 13G/A | JNCE / Jounce Therapeutics Inc | 4,259,653 | 0 | ||||
| 2024-02-14 | 13G/A | ISEE / IVERIC bio Inc | 7,878,119 | 0 | ||||
| 2024-02-14 | 13G/A | INZY / Inozyme Pharma, Inc. | 3,250,000 | 0 | ||||
| 2024-02-14 | 13G/A | IMVT / Immunovant, Inc. | 9,710,000 | 1,000,000 | ||||
| 2024-02-14 | 13G/A | IMUX / Immunic, Inc. | 4,022,989 | 0 | ||||
| 2024-02-14 | 13G/A | HRTX / Heron Therapeutics, Inc. | 12,232,267 | 0 | ||||
| 2024-02-14 | 13G/A | HLVX / HilleVax, Inc. | 2,900,000 | 2,900,000 | ||||
| 2024-02-14 | 13G/A | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 7,940,346 | 900,000 | ||||
| 2024-02-14 | 13G/A | GERN / Geron Corporation | 24,022,883 | 29,583,449 | ||||
| 2024-02-14 | 13G/A | FDMT / 4D Molecular Therapeutics, Inc. | 2,656,901 | 2,284,372 | ||||
| 2024-02-14 | 13G/A | EWTX / Edgewise Therapeutics, Inc. | 3,374,394 | 2,537,176 | ||||
| 2024-02-14 | 13G/A | ESPR / Esperion Therapeutics, Inc. | 6,345,790 | 0 | ||||
| 2024-02-14 | 13G/A | EDIT / Editas Medicine, Inc. | 4,493,416 | 5,473,086 | ||||
| 2024-02-14 | 13G/A | DYN / Dyne Therapeutics, Inc. | 4,500,000 | 2,000,000 | ||||
| 2024-02-14 | 13G/A | DVAX / Dynavax Technologies Corporation | 6,556,180 | 7,093,214 | ||||
| 2024-02-14 | 13G/A | AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) | 15,000,000 | 11,869,297 | ||||
| 2024-02-14 | 13G/A | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 2,819,045 | 3,490,506 | ||||
| 2024-02-14 | 13G/A | ATXS / Astria Therapeutics, Inc. | 1,816,531 | 0 | ||||
| 2024-02-14 | 13G/A | APGE / Apogee Therapeutics, Inc. | 3,023,456 | 2,323,456 | ||||
| 2024-02-14 | 13G/A | ANAB / AnaptysBio, Inc. | 1,360,176 | 2,036,990 | ||||
| 2024-02-14 | 13G/A | ALLK / Allakos Inc. | 5,000,000 | 2,510,736 | ||||
| 2024-02-14 | 13G/A | ALBO / Albireo Pharma Inc | 1,704,000 | 0 | ||||
| 2024-02-14 | 13G/A | AGEN / Agenus Inc. | 27,000,000 | 31,697,539 | ||||
| 2024-02-14 | 13G/A | ABOS / Acumen Pharmaceuticals, Inc. | 3,952,000 | 0 | ||||
| 2024-02-12 | 13G | IVVD / Invivyd, Inc. | 9,000,000 | |||||
| 2024-01-26 | 13G | ALLK / Allakos Inc. | 4,899,179 | 5,000,000 | ||||
| 2024-01-26 | 13G/A | ALLK / Allakos Inc. | 4,899,179 | 2,510,736 | ||||
| 2024-01-19 | 13G | DYN / Dyne Therapeutics, Inc. | 2,684,200 | 4,500,000 | ||||
| 2024-01-19 | 13G/A | DYN / Dyne Therapeutics, Inc. | 2,684,200 | 2,000,000 | ||||
| 2023-12-22 | 13G | OCUL / Ocular Therapeutix, Inc. | 9,230,769 | |||||
| 2023-11-02 | 13G | AMAM / Ambrx Biopharma Inc. | 3,710,412 | |||||
| 2023-11-02 | 13G | ALGS / Aligos Therapeutics, Inc. | 7,295,967 | |||||
| 2023-10-30 | 13G | ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) | 4,297,438 | |||||
| 2023-10-27 | 13G | TRML / Tourmaline Bio, Inc. | 1,815,854 | |||||
| 2023-10-23 | 13G | RAPT / RAPT Therapeutics, Inc. | 1,991,403 | |||||
| 2023-10-02 | 13G | ANAB / AnaptysBio, Inc. | 1,360,176 | |||||
| 2023-09-29 | 13G | HLVX / HilleVax, Inc. | 2,900,000 | |||||
| 2023-08-04 | 13G | EDIT / Editas Medicine, Inc. | 4,493,416 | |||||
| 2023-07-28 | 13G | TERN / Terns Pharmaceuticals, Inc. | 3,560,000 | |||||
| 2023-07-24 | 13G | APGE / Apogee Therapeutics, Inc. | 3,023,456 | |||||
| 2023-06-30 | 13G | AGLE / Aeglea BioTherapeutics Inc | 7,258,056 | |||||
| 2023-06-15 | 13G | ZURA / Zura Bio Limited | 4,205,000 | |||||
| 2023-05-19 | 13G | DVAX / Dynavax Technologies Corporation | 6,556,180 | |||||
| 2023-04-14 | 13G | NKTR / Nektar Therapeutics | 12,302,237 | |||||
| 2023-04-14 | 13G | SWTX / SpringWorks Therapeutics, Inc. | 3,254,132 | |||||
| 2023-03-20 | 13G | PLRX / Pliant Therapeutics, Inc. | 3,104,507 | |||||
| 2023-03-20 | 13G | ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock) | 19,125,150 | |||||
| 2023-02-24 | 13G | NRIX / Nurix Therapeutics, Inc. | 2,266,569 | 2,717,171 | ||||
| 2023-02-14 | 13G/A | KROS / Keros Therapeutics, Inc. | 1,300,000 | 0 | ||||
| 2023-02-14 | 13G/A | VRDN / Viridian Therapeutics, Inc. | 1,819,689 | 3,312,974 | ||||
| 2023-02-14 | 13G/A | TVTX / Travere Therapeutics, Inc. | 3,435,200 | 4,582,000 | ||||
| 2023-02-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,100,000 | 2,727,606 | ||||
| 2023-02-14 | 13G/A | TCDA / Tricida Inc | 5,857,829 | 4,666,666 | ||||
| 2023-02-14 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 2,481,000 | 2,837,818 | ||||
| 2023-02-14 | 13G/A | PASG / Passage Bio, Inc. | 3,216,997 | 0 | ||||
| 2023-02-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 2,436,164 | 2,266,569 | ||||
| 2023-02-14 | 13G/A | NUVB / Nuvation Bio Inc. | 11,471,281 | 8,221,188 | ||||
| 2023-02-14 | 13G/A | NKTX / Nkarta, Inc. | 1,965,684 | 1,354,200 | ||||
| 2023-02-14 | 13G/A | MGTA / Magenta Therapeutics Inc | 4,870,000 | 3,000,000 | ||||
| 2023-02-14 | 13G/A | MDGL / Madrigal Pharmaceuticals, Inc. | 917,825 | 0 | ||||
| 2023-02-14 | 13G/A | KURA / Kura Oncology, Inc. | 3,362,000 | 0 | ||||
| 2023-02-14 | 13G/A | KDNY / Chinook Therapeutics Inc | 2,752,070 | 3,000,000 | ||||
| 2023-02-14 | 13G/A | KALV / KalVista Pharmaceuticals, Inc. | 1,500,000 | 0 | ||||
| 2023-02-14 | 13G/A | ISEE / IVERIC bio Inc | 9,000,000 | 7,878,119 | ||||
| 2023-02-14 | 13G/A | JNCE / Jounce Therapeutics Inc | 4,000,000 | 4,259,653 | ||||
| 2023-02-14 | 13G/A | INZY / Inozyme Pharma, Inc. | 3,250,000 | 3,250,000 | ||||
| 2023-02-14 | 13G/A | IMUX / Immunic, Inc. | 4,022,989 | 4,022,989 | ||||
| 2023-02-14 | 13G/A | IMVT / Immunovant, Inc. | 6,780,827 | 9,710,000 | ||||
| 2023-02-14 | 13G/A | GBT / Global Blood Therapeutics Inc. | 3,646,690 | 0 | ||||
| 2023-02-14 | 13G/A | HOOK / HOOKIPA Pharma Inc. | 5,035,998 | 1,240,369 | ||||
| 2023-02-14 | 13G/A | FMTX / Forma Therapeutics Holdings Inc | 2,686,655 | 0 | ||||
| 2023-02-14 | 13G/A | DYN / Dyne Therapeutics, Inc. | 2,816,950 | 2,684,200 | ||||
| 2023-02-14 | 13G/A | FDMT / 4D Molecular Therapeutics, Inc. | 1,900,000 | 2,656,901 | ||||
| 2023-02-14 | 13G/A | AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) | 15,000,000 | 15,000,000 | ||||
| 2023-02-14 | 13G/A | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 1,496,138 | 2,819,045 | ||||
| 2023-02-14 | 13G/A | AUPH / Aurinia Pharmaceuticals Inc. | 7,841,570 | 324,238 | ||||
| 2023-02-14 | 13G/A | ATXS / Astria Therapeutics, Inc. | 1,816,531 | 1,816,531 | ||||
| 2023-02-14 | 13G/A | ASMB / Assembly Biosciences, Inc. | 3,000,000 | 1,833,437 | ||||
| 2023-02-14 | 13G/A | ALLK / Allakos Inc. | 4,518,575 | 4,899,179 | ||||
| 2023-02-14 | 13G/A | ARDX / Ardelyx, Inc. | 14,252,831 | 0 | ||||
| 2023-02-14 | 13G/A | AGEN / Agenus Inc. | 15,229,187 | 27,000,000 | ||||
| 2023-02-14 | 13G/A | ALBO / Albireo Pharma Inc | 1,124,421 | 1,704,000 | ||||
| 2023-02-14 | 13G/A | ABOS / Acumen Pharmaceuticals, Inc. | 2,414,917 | 3,952,000 | ||||
| 2023-02-03 | 13G | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 7,940,346 | |||||
| 2023-01-13 | 13G | GERN / Geron Corporation | 24,022,883 | |||||
| 2022-12-22 | 13G | ATXS / Astria Therapeutics, Inc. | 1,816,531 | |||||
| 2022-12-19 | 13G | AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) | 15,000,000 | |||||
| 2022-10-28 | 13G | AUPH / Aurinia Pharmaceuticals Inc. | 7,841,570 | |||||
| 2022-10-21 | 13G | RLMD / Relmada Therapeutics, Inc. | 2,481,000 | |||||
| 2022-10-20 | 13G | IMUX / Immunic, Inc. | 4,022,989 | |||||
| 2022-10-07 | 13G | VALN / Valneva SE - Depositary Receipt (Common Stock) | 10,513,265 | |||||
| 2022-10-03 | 13G | ALBO / Albireo Pharma Inc | 1,124,421 | |||||
| 2022-09-30 | 13G | ALLK / Allakos Inc. | 4,518,575 | |||||
| 2022-09-23 | 13G | EWTX / Edgewise Therapeutics, Inc. | 3,374,394 | |||||
| 2022-09-19 | 13G | SYRS / Syros Pharmaceuticals, Inc. | 699,281 | |||||
| 2022-09-16 | 13G | ISEE / IVERIC bio Inc | 9,000,000 | |||||
| 2022-09-12 | 13G | ARDX / Ardelyx, Inc. | 14,252,831 | |||||
| 2022-08-22 | 13G | VIGL / Vigil Neuroscience, Inc. | 3,684,619 | |||||
| 2022-08-22 | 13G | SLNCF / Silence Therapeutics plc | 5,854,740 | |||||
| 2022-08-19 | 13G | HRTX / Heron Therapeutics, Inc. | 12,232,267 | |||||
| 2022-07-06 | 13G | ETNB / 89bio, Inc. | 4,331,499 | |||||
| 2022-06-23 | 13G | NUVB / Nuvation Bio Inc. | 11,471,281 | |||||
| 2022-06-17 | 13G | GBT / Global Blood Therapeutics Inc. | 3,646,690 | |||||
| 2022-06-10 | 13G | NRIX / Nurix Therapeutics, Inc. | 2,436,164 | |||||
| 2022-06-03 | 13G | FMTX / Forma Therapeutics Holdings Inc | 2,686,655 | |||||
| 2022-05-19 | 13G | MDGL / Madrigal Pharmaceuticals, Inc. | 917,825 | |||||
| 2022-05-16 | 13G | TVTX / Travere Therapeutics, Inc. | 2,450,000 | 3,435,200 | ||||
| 2022-04-18 | 13G | INZY / Inozyme Pharma, Inc. | 3,250,000 | |||||
| 2022-04-08 | 13G | AGEN / Agenus Inc. | 15,229,187 | |||||
| 2022-03-04 | 13G | HOOK / HOOKIPA Pharma Inc. | 5,035,998 | |||||
| 2022-02-18 | 13G | NKTX / Nkarta, Inc. | 1,965,684 | |||||
| 2022-02-16 | 13G | KDNY / Chinook Therapeutics Inc | 2,752,070 | |||||
| 2022-02-14 | 13G/A | CRNX / Crinetics Pharmaceuticals, Inc. | 1,898,666 | 1,900,000 | ||||
| 2022-02-14 | 13G/A | TVTX / Travere Therapeutics, Inc. | 3,090,200 | 2,450,000 | ||||
| 2022-02-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,104,600 | 2,100,000 | ||||
| 2022-02-14 | 13G/A | AVRO / AVROBIO, Inc. | 2,211,129 | 1,050,132 | ||||
| 2022-02-14 | 13G/A | MGTA / Magenta Therapeutics Inc | 4,155,555 | 4,870,000 | ||||
| 2022-02-14 | 13G/A | PASG / Passage Bio, Inc. | 2,852,940 | 3,216,997 | ||||
| 2022-02-14 | 13G/A | KALV / KalVista Pharmaceuticals, Inc. | 1,266,884 | 1,500,000 | ||||
| 2022-02-14 | 13G/A | KROS / Keros Therapeutics, Inc. | 1,288,724 | 1,300,000 | ||||
| 2022-02-14 | 13G/A | FDMT / 4D Molecular Therapeutics, Inc. | 1,800,000 | 1,900,000 | ||||
| 2022-02-14 | 13G/A | JNCE / Jounce Therapeutics Inc | 3,856,463 | 4,000,000 | ||||
| 2022-02-14 | 13G/A | ASMB / Assembly Biosciences, Inc. | 2,393,876 | 3,000,000 | ||||
| 2022-02-11 | 13G | IMVT / Immunovant, Inc. | 6,780,827 | |||||
| 2022-02-04 | 13G | KURA / Kura Oncology, Inc. | 3,362,000 | |||||
| 2022-01-27 | 13G | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 1,496,138 | |||||
| 2022-01-27 | 13G | ABOS / Acumen Pharmaceuticals, Inc. | 2,414,917 | |||||
| 2022-01-20 | 13G | DYNE / Dyntek Inc | 2,816,950 | |||||
| 2021-12-30 | 13G | KROS / Keros Therapeutics, Inc. | 1,288,724 | |||||
| 2021-12-09 | 13G | ESPR / Esperion Therapeutics, Inc. | 6,345,790 | |||||
| 2021-11-17 | 13G | TCDA / Tricida Inc | 5,857,829 | |||||
| 2021-11-04 | 13G | FDMT / 4D Molecular Therapeutics, Inc. | 1,800,000 | |||||
| 2021-10-29 | 13G | RPTX / Repare Therapeutics Inc. | 2,104,600 | |||||
| 2021-10-25 | 13G | KALV / KalVista Pharmaceuticals, Inc. | 1,266,884 | |||||
| 2021-10-25 | 13G | PASG / Passage Bio, Inc. | 2,852,940 | |||||
| 2021-10-12 | 13G | ASMB / Assembly Biosciences, Inc. | 2,393,876 | |||||
| 2021-09-24 | 13G | VRDN / Viridian Therapeutics, Inc. | 1,819,689 | |||||
| 2021-09-01 | 13G | JNCE / Jounce Therapeutics Inc | 3,856,463 | |||||
| 2021-08-13 | 13G | TVTX / Travere Therapeutics, Inc. | 3,090,200 | |||||
| 2021-08-05 | 13G | AVRO / AVROBIO, Inc. | 2,211,129 | |||||
| 2021-05-14 | 13G | MGTA / Magenta Therapeutics Inc | 4,155,555 | |||||
| 2021-04-22 | 13G | CRNX / Crinetics Pharmaceuticals, Inc. | 1,898,666 |
